178 related articles for article (PubMed ID: 11462165)
21. Pseudomonas aeruginosa keratitis in leukopenic rabbits.
Hobden JA; Engel LS; Callegan MC; Hill JM; Gebhardt BM; O'Callaghan RJ
Curr Eye Res; 1993 May; 12(5):461-7. PubMed ID: 8344069
[TBL] [Abstract][Full Text] [Related]
22. Mechanism of Pseudomonas aeruginosa Small Protease (PASP), a Corneal Virulence Factor.
Tang A; Caballero AR; Marquart ME; Bierdeman MA; O'Callaghan RJ
Invest Ophthalmol Vis Sci; 2018 Dec; 59(15):5993-6002. PubMed ID: 30572344
[TBL] [Abstract][Full Text] [Related]
23. Role of IL-12 and IFN-gamma in Pseudomonas aeruginosa corneal infection.
Hazlett LD; Rudner XL; McClellan SA; Barrett RP; Lighvani S
Invest Ophthalmol Vis Sci; 2002 Feb; 43(2):419-24. PubMed ID: 11818386
[TBL] [Abstract][Full Text] [Related]
24. Role of exoproteins in bacterial keratitis: the Fourth Annual Thygeson Lecture, presented at the Ocular Microbiology and Immunology Group Meeting, November 7, 1998.
O'Callaghan RJ
Cornea; 1999 Sep; 18(5):532-7. PubMed ID: 10487425
[No Abstract] [Full Text] [Related]
25. Characterization of virulence factors, antimicrobial resistance patterns and biofilm formation of Pseudomonas aeruginosa and Staphylococcus spp. strains isolated from corneal infection.
Heidari H; Hadadi M; Sedigh Ebrahim-Saraie H; Mirzaei A; Taji A; Hosseini SR; Motamedifar M
J Fr Ophtalmol; 2018 Nov; 41(9):823-829. PubMed ID: 30292385
[TBL] [Abstract][Full Text] [Related]
26. Contribution of ExsA-regulated factors to corneal infection by cytotoxic and invasive Pseudomonas aeruginosa in a murine scarification model.
Lee EJ; Cowell BA; Evans DJ; Fleiszig SM
Invest Ophthalmol Vis Sci; 2003 Sep; 44(9):3892-8. PubMed ID: 12939306
[TBL] [Abstract][Full Text] [Related]
27. Molecular analysis of Pseudomonas aeruginosa protease IV expressed in Pseudomonas putida.
Traidej M; Caballero AR; Marquart ME; Thibodeaux BA; O'Callaghan RJ
Invest Ophthalmol Vis Sci; 2003 Jan; 44(1):190-6. PubMed ID: 12506074
[TBL] [Abstract][Full Text] [Related]
28. Correlation of
Caballero AR; Tang A; Bierdeman M; O'Callaghan R; Marquart M
Curr Eye Res; 2021 May; 46(5):638-647. PubMed ID: 32938252
[TBL] [Abstract][Full Text] [Related]
29. Secreted LasA of Pseudomonas aeruginosa is a staphylolytic protease.
Kessler E; Safrin M; Olson JC; Ohman DE
J Biol Chem; 1993 Apr; 268(10):7503-8. PubMed ID: 8463280
[TBL] [Abstract][Full Text] [Related]
30. Staphylococcus aureus infection of the rabbit cornea following topical administration.
Tang A; Balzli CL; Caballero AR; McCormick CC; Taylor SD; O'Callaghan RJ
Curr Eye Res; 2012 Dec; 37(12):1075-83. PubMed ID: 22916736
[TBL] [Abstract][Full Text] [Related]
31. Impact of topical corticosteroid pretreatment on susceptibility of the injured murine cornea to Pseudomonas aeruginosa colonization and infection.
Wu YT; Truong TN; Tam C; Mendoza MN; Zhu L; Evans DJ; Fleiszig SMJ
Exp Eye Res; 2019 Feb; 179():1-7. PubMed ID: 30343040
[TBL] [Abstract][Full Text] [Related]
32. Regulation of Pseudomonas aeruginosa corneal infection in IL-1 beta converting enzyme (ICE, caspase-1) deficient mice.
Thakur A; Barrett RP; McClellan S; Hazlett LD
Curr Eye Res; 2004; 29(4-5):225-33. PubMed ID: 15590467
[TBL] [Abstract][Full Text] [Related]
33. Twitching motility contributes to the role of pili in corneal infection caused by Pseudomonas aeruginosa.
Zolfaghar I; Evans DJ; Fleiszig SM
Infect Immun; 2003 Sep; 71(9):5389-93. PubMed ID: 12933890
[TBL] [Abstract][Full Text] [Related]
34. Nona-D-arginine therapy for Pseudomonas aeruginosa keratitis.
Karicherla P; Hobden JA
Invest Ophthalmol Vis Sci; 2009 Jan; 50(1):256-62. PubMed ID: 18775859
[TBL] [Abstract][Full Text] [Related]
35. Effect of Pseudomonas aeruginosa concentration in experimental contact lens-related microbial keratitis.
Lawin-Brüssel CA; Refojo MF; Leong FL; Hanninen L; Kenyon KR
Cornea; 1993 Jan; 12(1):10-8. PubMed ID: 8458227
[TBL] [Abstract][Full Text] [Related]
36. Mutation of the phospholipase catalytic domain of the Pseudomonas aeruginosa cytotoxin ExoU abolishes colonization promoting activity and reduces corneal disease severity.
Tam C; Lewis SE; Li WY; Lee E; Evans DJ; Fleiszig SM
Exp Eye Res; 2007 Dec; 85(6):799-805. PubMed ID: 17905228
[TBL] [Abstract][Full Text] [Related]
37. Corneal virulence of Pseudomonas aeruginosa elastase B and alkaline protease produced by Pseudomonas putida.
Thibodeaux BA; Caballero AR; Marquart ME; Tommassen J; O'Callaghan RJ
Curr Eye Res; 2007 Apr; 32(4):373-86. PubMed ID: 17453960
[TBL] [Abstract][Full Text] [Related]
38. Comparison of besifloxacin, gatifloxacin, and moxifloxacin against strains of pseudomonas aeruginosa with different quinolone susceptibility patterns in a rabbit model of keratitis.
Sanders ME; Moore QC; Norcross EW; Sanfilippo CM; Hesje CK; Shafiee A; Marquart ME
Cornea; 2011 Jan; 30(1):83-90. PubMed ID: 20847656
[TBL] [Abstract][Full Text] [Related]
39. Pathogenesis of the mouse keratitis produced with Pseudomonas aeruginosa.
Kawaharajo K; Homma JY
Jpn J Exp Med; 1975 Dec; 45(6):515-24. PubMed ID: 822189
[TBL] [Abstract][Full Text] [Related]
40. Proteomic analysis of keratitis-associated Pseudomonas aeruginosa.
Sewell A; Dunmire J; Wehmann M; Rowe T; Bouhenni R
Mol Vis; 2014; 20():1182-91. PubMed ID: 25221424
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
